Director-General Charles Liao visited PharmaEssentia Innovation Research Center Corporation
分享到
PharmaEssentia Corporation, a global biopharmaceutical innovator headquartered in Taiwan, opened a new PharmaEssentia Innovation Research Center (PIRC) in Massachusetts in June 2023. TECO-Boston Director-General Charles Liao and Director Motion Tsai visited PIRC yesterday and were received by PharmaEssentia’s Founder and Chief Executive Officer, Ko-Chung Lin. Director-General Liao thanked Dr. Lin for the informative visit, and expressed hope that the PIRC will help further enhance cooperation and exchanges between Taiwan and US in researches including biotechnology, artificial intelligence (AI) and precision medicine, among other areas in Taiwan’s Six Core Strategic Industries.
